News & views
This channel includes the latest news, interviews and opinion pieces on all aspects of regenerative medicine from around the world, aiming to keep you up to date with the field and aware of different insights and perspectives.
Why the FDA’s CAR-T approval sends strong signal to cell therapy industry: an interview with Martin Lamb
ISCT revises cell and gene therapy forecast following FDA approval of Novartis CAR-T therapy
Commercializing regenerative medicine in the early days of a revolution: an interview with Mahendra Rao
U.S. Stem Cell Clinics and International Businesses Are Registering For-Profit, Pay-to-Participate “Studies” on ClinicalTrials.gov